key: cord-0761185-dmu4qlgd
authors: Lari, Eisa; Lari, Ali; AlQinai, Shamlan; Abdulrasoul, Mahdi; Al-Safran, Salman; Ameer, Ahmad; Al-Sabah, Salman
title: Severe ischemic complications in Covid-19 - A Case series
date: 2020-09-10
journal: Int J Surg Case Rep
DOI: 10.1016/j.ijscr.2020.09.009
sha: 85c5dc65ed3a8fb0e95537d1590eca5a5b6e962c
doc_id: 761185
cord_uid: dmu4qlgd

INTRODUCTION: Covid-19 has the propensity to result in a wide array of manifestations. Recently, thromboembolic complications of Covid-19 have been denoted in literature. We report 5 cases of Covid-19 positive patients with no significant comorbidities who developed 1(st) time episodes of either; acute limb ischemia or bowel ischemia. MATERIAL AND METHODS: This is a retrospective observational study analyzing the clinical characteristics and outcomes of five Covid-19 positive patients. Five patients aged 38-60 presented to our institution from 1(st) April to 1(st) June and were diagnosed with Covid-19 pneumonia, subsequently developing severe vascular complications. None of our patients included had any history of thromboembolism nor risk factors that could justify the presentations. PRESENTATION OF CASES: Patient 1; presented with bowel ischemia as a first presentation. Patient 2 and 3 developed unsalvageable lower limb ischemia secondary to partial to complete occlusion of infra-renal aorta. Patient 4 presented with acute upper limb ischemia due to complete occlusion of the axillary and brachial artery. Patient 5 developed bilateral lower limb unsalvageable ischemia secondary to aortic bifurcation occlusion. All patients tested Covid-19 positive upon admission, and received standard care. DISCUSSION AND CONCLUSION: The thromboembolic complications seen in our cases were devastating and resulted in significant mortality and morbidity. All vessels affected were medium-large vessels. None of our cases had any significant predisposing medical conditions or history of thromboembolic or ischemic events. A high index of suspicion is necessary when evaluating such patients regardless of thromboembolic history. Appropriate anticoagulation regimens are essential. Our cases add to the currently increasing severe thromboembolic complications of Covid-19.

Covid-19 has the propensity to result in a wide array of manifestations. Recently, thromboembolic complications of Covid-19 have been denoted in literature. We report 5 cases of Covid-19 positive patients with no significant comorbidities who developed 1 st time episodes of either; acute limb ischemia or bowel ischemia.

This is a retrospective observational study analyzing the clinical characteristics and outcomes of five Covid-19 positive patients. Five patients aged 38-60 presented to our institution from 1 st April to 1 st June and were diagnosed with Covid-19 pneumonia, subsequently developing severe vascular complications. None of our patients included had any history of thromboembolism nor risk factors that could justify the presentations.

Covid-19 seems to have the propensity to result in a wide array of manifestations. It was declared a pandemic by the World Health Organization in March 2020 [11] . In recent observational studies, an association between venous and arterial thromboembolic disease and inflammatory response caused by Covid-19 has been linked [1, 2] . Yet the exact pathophysiology, incidence and prevalence have not been precisely described.

Potentially lethal Covid-19 associated hypercoagulable states have been described [17, 18] . Klok et al describes a thrombotic complication incidence of 31%; primarily venous, in ICU patients despite anticoagulation prophylaxis [4] . Lodigiani et al, described a remarkably increased incidence of arterial and venous vessel disease associated with increased mortality rates. Anticoagulation with heparin has been recommended and associated with decreased mortality rates [14, 16, 17, 19] . Similarly to the study we propose, evidence of medium to large vessel thrombotic complications have been reported in patients as young as 33 years old [12] .

The aim of our study is to describe the characteristics, course and outcomes of patients who are Covid-19 positive and presenting with unexpected or unexplained arterial and venous vessel disease. This research has been reported in line with the PROCESS criteria [20] . This study was registered as a case series on the www.researchregistry.com website with UIN 5853.

We report 5 cases of ischemic vessel disease in patients aged 36-60 to our healthcare services in Kuwait from the 1 st April 2020 to 1 st June 2020. All cases were diagnosed with Covid-19 pneumonia and tested positive via polymerase chain reaction (PCR). It is important to note that all patients were tested for Covid-19 as per strict hospital policies.

All of our patients received airway and breathing support along with recommended regimens of anticoagulation. Furthermore all patients were tested for coagulopathies by J o u r n a l P r e -p r o o f serological testing and were negative with low/ clinically insignificant titers. All patients received anticoagulation and were followed with coagulation markers; international normalized ratio (INR) and activated partial thrombosplastin time (APTT)

We included patients who did not have a history of coagulopathy or significant comorbidities that can justify such presentations. None of the patients had any history of previous thromboembolism, malignancy, long-haul travel or prolonged immobilization. Patients who had peripheral distal extremity ischemia were not included. Any patient with a prior history of thromboembolic or was at high risk of thromboembolic disease was not included.

A 38 year old male with no identifiable co-morbidities presented to the emergency department complaining of a 2-day history of progressively worsening abdominal pain, nausea, intractable vomiting and shortness of breath. Examination reveals tachycardia, respiratory distress, and abdominal pain out of proportion to the palpation. Apart from mild leukocytosis and a lactate of 2.2 mmol/L, D-Dimer 2100 ng/ml. All other laboratory investigations were normal. After normal plain films of the abdomen and chest, the patient underwent a computed tomography (CT) scan of the abdomen with contrast.

The scan revealed extensive thrombosis of the portal, splenic, superior and inferior mesenteric veins. The mid-portion of the small bowel was suggestive of venous ischemia. No pneumatosis intestinalis was noted. An incidental finding of a totally occluded right pulmonary artery consistent with a pulmonary embolism was noted.

The patient received heparin therapy prior to a diagnostic laparoscopy. Intra-operatively a markedly dusky jejunal segment was identified along with turbid fluid in all quadrants. Conversion to open laparotomy ensued followed by resection of the diseased segment with temporary abdominal closure (Fig.1) . The patient was admitted to the ICU for resuscitation and anticoagulation. The patient was later taken to theatre for a side to side anastomosis. The patient was subsequently placed on extracorporeal membrane oxygenation (ECMO) and is currently under care in the intensive care unit (ICU). A 48 year old male with a history of asthma presented to our institution with a cough, shortness of breath and a fever. The patient subsequently tested positive for Covid-19 and was intubated and admitted to the ICU with hypoxic respiratory failure after failure to improve with initial therapy. The patient was started on therapeutic enoxaparin treatment.

On the 10th day the patient was on high ventilator settings and minimal inotropic support. On examination, lower limbs showed unsalvageable ischemia with no palpable pulses (Fig.2) . Urgent CT angiography revealed complete occlusion of the left arterial tree from the aortic bifurcation descending down to the infra-popliteal arteries. Contralaterally, distal occlusion of the superficial femoral artery down to the infra-popliteal arteries. CT of the lung displayed ground glass appearance of the lungs associated with consolidation. After consulting the next of kin and the risk; benefit of proceeding to surgery. The joint decision to provide supportive care was made. The patient was declared dead on the same day. 

A 60 year old hypertensive male presented to our institution with significant respiratory distress. He was subsequently intubated in the ER due to deteriorating respiratory status and reduced level of consciousness. On day 8 of his ICU course, the left lower limb appeared dusky and mottled up to the mid-thigh (Fig. 3) . The right distal forefoot displayed a well demarcated discoloration.

CT angiography revealed; Infra-renal aortic left sided eccentric, non-calcified atheromatous plaque. Significant occlusion of the left common iliac artery extending to infra-popliteal arteries. A joint decision was made to avoid surgery given the poor prognosis associated with severe acute respiratory distress syndrome and high inotropic support. The patient expired the following morning. 

A 38 year old previously healthy male presented to our ER complaining of a 2 day history of worsening left arm pain and mild shortness of breath. On examination a discolored left arm was noted and markedly reduced/absent pulses. The patient was afebrile and the only abnormal laboratory investigations was a D-Dimer of 1500 ng/ml. CT-angiography showed a totally occluded left axillary artery and partial occlusion of the brachial arterylikely embolic. Bilateral pulmonary embolism noted on subsequent CT scan.

Heparin infusion was initiated and a surgical embolectomy performed successfully. The patient was admitted to the ICU for observation management. The patient recovered and was discharged after 2 weeks.

A 58 year old previously healthy male who presented to us after being diagnosed with Covid-19 pneumonia. On arrival the patient was displaying signs of severe respiratory distress with exhaustion. He was immediately intubated and transferred to the ICU. During his stay he was on high ventilatory and inotropic support. On day 11, all distal extremities showed non salvageable ischemia with no palpable distal pulses (Fig 4) . Urgent CT angiography revealed extensive thrombosis affecting aortic bifurcation and bilateral iliac systems. Despite aggressive anticoagulation the patient subsequently expired secondary to refractory shock. The patient was anti-coagulated for the entire duration of his hospital stay. 

Our cases represent further evidence of the propensity for Covid-19 to present with unexpected vessel disease in seemingly healthy patients. These unusual cases should arouse clinical suspicion even in patients who are not predisposed to venous and arterial disease. The striking feature displayed is the thromboembolic propensity despite adequate prophylactic and therapeutic doses of anticoagulation.

In our institution; the main Covid-19 hospital in Kuwait. All of our patients received recommended doses of prophylactic and therapeutic enoxaparin, with some patients placed on heparin infusions upon admission based on existing recommendations and expert consensus. Our institution found that these cases differ significantly from patients suffering from distal extremity ischemia, confined to the distal phalanx and likely secondary to vasopressor infusions.

In Conclusion, despite the limited number of cases, we believe these cases to be significant additions and may aid further research. Presentations such as these are relatively rare. We believe Covid-19 plays a vital role in thromboembolic disease and warrants a high index of suspicion regardless of predisposing factors. A registry would need to be set up and further high level studies need to be carried out, to underline the etiology and treatment recommendations.

Eisa Lari -Writing original draft, review and editing Ali Lari -Writing original draft, review and editing Shamlan AlQinai -Writing original draft, data collection Mahdi Abdulrasoul -Data collection Salman Al-Safran -Supervision, visualization Ahmed Ameer -conceptualization, reviewing Salman Al-Sabah -Conceptualization

Hyperlink to your specific registration

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Gomes Hypercoagulable syndromes: evaluation and management strategies for acute limb ischemia

Prominent changes inblood coagulation of patients with SARS-CoV-2 infection

Acute limb ischemia in patients with COVID-19 pneumonia

Acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia

Why Not Life and Limb? Vasopressor Use in Intensive Care Unit Patients the Cause of Acute

WHO Declares COVID-19 a Pandemic

Large-vessel stroke as a presenting feature of Covid-19 in the young

COVID-19 update: Covid-19-associated coagulopathy

COVID-19) Treatment Guidelines. National Institutes of Health

Anticoagulation in COVID-19

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging J o u r n a l P r e -p r o o f evidence and call for action

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill

SCARE Group The PROCESS 2018 statement: updating consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) guidelines

The authors declare no conflict of interest.

The authors declare that they have no source of funding to disclose.

Written consent was obtained from the patients and/or patient's family where possible.

The study is exempt from ethical approval in our institution Data observational study only